Martine A Rothblatt, Director, Chairperson & CEO, on May 29, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,261,365. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1082554/000110657826000065/xslF345X05/primarydocument.xml